UK Spinal Muscular Atrophy Patient Registry
study id #: NCT04292574
condition: Spinal Muscular Atrophy, SMA
status: Recruiting
purpose:Spinal Muscular Atrophy (SMA) is a group of different genetic disorders which manifest themselves in muscle weakness due to loss of motor neurons in the spinal cord and brainstem. SMA is an autosomal recessive disorder therefore all forms of SMA are caused by inheritance of a mutated gene from each parent. If both parents are carriers each infant has a 25% chance of developing the illness. All forms of SMA have an estimated combined incidence of 1 in 6,000 to 1 in 10,000 live births, with a carrier frequency of 1/40-1/60. SMA is the second most common fatal autosomal recessive disorder after cystic fibrosis.
The aim is to facilitate a questionnaire based research study in order to better characterise and understand the disease in the UK. By maintaining a national registry this will help identify potential participants eligible for clinical trials in the future.
intervention: Patient Registry
results: https://clinicaltrials.gov/ct2/show/results/NCT04292574
last updated: February 04, 2022
-
Your Guide to Spinal Muscular Atrophyhttps://simedhealth.com/sites/default/fi...
-
Matthew Harms, MDMatthew Harms, MD is an Associate Profes...
-
Systematic Literature Review to Assess the Cost and Resource Use Associated With Spinal Muscular Atrophy ManagementSpinal muscular atrophy (SMA) is a sever...
-
DNA From Saliva Has Potential for Detecting SMAA noninvasive method using dried saliva ...
-
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult With 5q-Related Spinal Muscular Atro...Spinal muscular atrophy (SMA) is a hered...
-
Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database AnalysisSpinal muscular atrophy (SMA) is a rare,...
-
Artist With SMA Pens Song ‘SPACES’ About Looking Beyond DisabilityA song written and performed by an artis...